These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32305289)

  • 21. Early medical abortion in India: three studies and their implications for abortion services.
    Coyaji K
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):191-4. PubMed ID: 10846337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second trimester medical abortion in a primigravida with lupus nephritis and rapidly progressive renal failure: challenges and outcome.
    Bagga R; Sharma B; Choudhary N; Singla R; Saha PK; Bharati J; Rajkumar Kopp C; Jain S
    Eur J Contracept Reprod Health Care; 2021 Apr; 26(2):171-173. PubMed ID: 33615941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent use of mifepristone and misoprostol for early medical abortion.
    Li YT; Chen FM; Chen TH; Li SC; Chen ML; Kuo TC
    Taiwan J Obstet Gynecol; 2006 Dec; 45(4):325-8. PubMed ID: 17175491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion.
    Kapp N; Borgatta L; Ellis SC; Stubblefield P
    Contraception; 2006 May; 73(5):525-7. PubMed ID: 16627039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone.
    Arvidsson C; Hellborg M; Gemzell-Danielsson K
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):87-91. PubMed ID: 16260342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
    Richardson CR
    J Fam Pract; 2001 Jan; 50(1):9. PubMed ID: 11195490
    [No Abstract]   [Full Text] [Related]  

  • 31. Induction of delivery by mifepristone and misoprostol in termination of pregnancy and intrauterine fetal death: 2nd and 3rd trimester induction of labour.
    Stibbe KJ; de Weerd S
    Arch Gynecol Obstet; 2012 Sep; 286(3):795-6. PubMed ID: 22434057
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First trimester abortion with mifepristone and vaginal misoprostol.
    Knudsen UB
    Contraception; 2001 May; 63(5):247-50. PubMed ID: 11448463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical abortion: a fact sheet.
    Berer M
    Reprod Health Matters; 2005 Nov; 13(26):20-4. PubMed ID: 16366018
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of Misoprostol for medical abortion: a trial of the acceptability for home use].
    Dagousset I; Fourrier E; Aubény E; Taurelle R
    Gynecol Obstet Fertil; 2004 Jan; 32(1):28-33. PubMed ID: 14736597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of concurrent administration of mifepristone and misoprostol for termination of pregnancy.
    Verma ML; Singh U; Singh N; Sankhwar PL; Qureshi S
    Hum Fertil (Camb); 2017 Apr; 20(1):43-47. PubMed ID: 27804310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. US state classifies mifepristone and misoprostol as dangerous controlled substances.
    Tanne JH
    BMJ; 2024 May; 385():q1175. PubMed ID: 38811049
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.